Tag: OZSC

Penny Stock Runners, Fresh Options Ideas

Solid Penny Runners 

In yesterday morning’s premarket report, we generated an extended watchlist comprised solely of OTC-traded penny stocks. What happened was a really good example of why we don’t cover only the big boards and options plays. We keep our offerings as diverse as we can and simply follow where good opportunities lead.

Several of the stocks we tagged for observation produced very nice intraday moves and potential gains for us, which were as follows: 

Ozop Energy Solutions, Inc. OZSC
Intraday Range: .0131-.03
Potential Gain: 129%
_____

Defense Technologies International Corp. DTII
Intraday Range: .0176-.0312
Potential Gain: 77%
_____

Sun Pacific Holding Corp. SNPW
Intraday Range: .0022-.003
Potential Gain: 36%
_____

Hop-On Inc. HPNN
Intraday Range: .0017-.003
Potential Gain: 76%
_____

Alternet Systems, Inc. ALYI (Initially Called on Thursday)
Intraday Range: .0152-.0375
Potential Gain: 147%

Fresh Options Ideas:
HHC 02/19 $80-90 Calls
FUBO 02/12 $33.54-35 Calls
ACI Weekly $17.50 Calls
VOXX Weekly $17.50-22.50 Calls

Extended Watchlist:
NXGB, ATVK, AABB, OPTI, ENZC, TSCRF, WNDW, 

CURR News Update & More

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

We’re looking back in on CURR this morning on the heels of a key PR released by the company that we would like to share with our readers. We have been following this stock for roughly a month, and this FDA IND approval news is by far the most exciting development yet.

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for its product CUREfilm Blue™, an oral soluble film of sildenafil citrate (the active ingredient present in Viagra®1) for the treatment of erectile dysfunction (ED). CURE is seeking approval of this product via the 505(b)(2) regulatory pathway to expedite the U.S. approval process. (>>View Full PR via OTCMARKETS)

In addition to familiarizing yourself with the company’s news update, we would recommend you take a couple of minutes to check out the video presentation of the CURR chart that we have provided below: 


______

Please direct any investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Fresh Options Ideas:
SPY 01/06 $368-367 Puts

Extended Watchlist: 
TSPG, WDLF, ISWH, USRM, OZSC, LBRMF

Options Gains, Fresh Idea

Trip.com Group Ltd. TCOM

We’ve been tracking a set of calls in the TCOM chain since Friday morning, when we alerted on the TCOM 10/16 $27-29 Calls. Leading into yesterday’s session they had recorded some modest gains, and for the second session in a row yesterday we saw higher highs.

Here are the total ranges and potential profits that our TCOM targets have netted over two trading days: 

TCOM 10/16 $27-29 Calls 
$27: 2.62-4.40 (+68%)
$28: 1.88-4.16 (+121%)
$29: 1.18-3.20 (+171%)

Uber Technologies Inc. UBER

We also had some fresh ideas in yesterday’s report, one of which being in the UBER chain. We signaled interest in tracking the UBER Weekly $34.50-36 Calls and all four of those sets posted some respectable upswings on the day:

UBER Weekly $34.50-36 Calls
$34.50: 1.36-2.29 (+68%)
$35: 1.02-1.90 (+86%)
$35.50: .73-1.54 (+111%)
$36: .58-1.22 (+110%)

Fresh Options Idea: 
MKC 10/16 $195 Puts 

Extended Watchlist:
CLIS, CLOW, UEEC, OZSC, GAXY, GAHC